Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol STEAP4 contributors: mct - updated : 04-06-2014
HGNC name STEAP family member 4
HGNC id 21923
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • a long N-terminal tail predicted to have NADP+/NADPH oxidoreductase activity
  • utilizes potentially an interdomain flavin-binding site to shuttle electrons between the oxidoreductase and transmembrane domains
  • HOMOLOGY
    intraspecies homolog to STAMP1
    Homologene
    FAMILY
  • six-transmembrane epithelial antigen of prostate (Steap) family proteins
  • CATEGORY antigen , transport channel
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,Golgi
    intracellular,cytoplasm,organelle,endosome
    text
  • primarily localized to the Golgi complex, trans-Golgi network, and the plasma membrane
  • also localizes to vesicular-tubular structures in the cytosol and colocalizes with the Early Endosome Antigen1 (EEA1)
  • resides predominantly in endosomes and may functions as a ferrireductase in osteoclast lineage cells as it does in other cells
  • basic FUNCTION
  • may be participating in adipocyte development and metabolism and mediating some TNF alpha effects on the fat cell as a channel or a transporter
  • may contribute to the normal biology of the prostate cell, as well as prostate cancer progression
  • critical modulator of this integrated response system of inflammation and metabolism in adipocytes
  • participating in integrating inflammatory and metabolic responses and thus playing a key role in systemic metabolic homeostasis
  • acting in a similar regulatory capacity in response to acute nutritional challenges or chronic hyperglycemia
  • might modulate proinflammatory and insulin resistance-inducing effects of IL1B (Kralisch 2009)
  • plasma membrane metalloreductase involved in the transport of iron and copper
  • transcriptional regulation of hepatic STEAP4 may play a critical role in the response to nutritional and inflammatory stress and contributes to the protective effect of STEAP4
  • STEAP1, STEAP2, STEAP3, STEAP4 share an innate activity as metalloreductases, indicating their importance in metal metabolism
  • STEAP4 and LCN2 mRNA and protein levels in visceral adipose tissue are related to iron status
  • is a critical enzyme for cellular iron uptake and utilization in osteoclasts and, thus, indispensable for osteoclast development and function
  • is a novel anti-obesity gene that is significantly down-regulated in adipose tissue of obese patients
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    may be involved in the secretory/endocytic pathways
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • TNF, IL6, and leptin, which have been implicated in insulin sensitivity regulation, regulate the expression of STEAP4
  • cell & other
    REGULATION
    activated by IL1B in a dose- and time-dependent fashion in 3T3-L1 adipocytes (Kralisch 2009)
    induced by interleukin 6 (IL6)
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in prostate cancer cells compared with normal prostate epithelial cells
    constitutional     --other  
    deficiency is sufficient to spontaneously recapitulate many cardinal features of the metabolic syndrome, including inflammation, insulin resistance, glucose intolerance, mild hyperglycemia, dyslipidemia, and fatty infiltration of liver
    constitutional     --over  
    can improve glucose uptake and mitochondrial function, and increase insulin sensitivity
    constitutional     --over  
    during osteoclast differentiation
    constitutional     --low  
    might reflect visceral adipose dysfunction in subjects with obesity and type 2 diabetes
    constitutional     --low  
    in metabolic syndrome, especially women patients, down-regulated in peripheral blood mononuclear cell, which was correlated with carotid atherosclerosis and cardiac adaptation
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS
  • STEAP4-deficiency in mice leads to overt inflammation and development of spontaneous metabolic disease on a regular diet characterized by insulin resistance, glucose intolerance, mild hyperglycemia, dyslipidemia, and fatty liver disease (Kralisch 2009)
  • loss of Steap4 expression in mice leads to increased production of inflammatory cytokines in visceral white adipose tissue and systemic insulin resistance